ATE113949T1 - Alpha-adrenergische rezeptorantagonisten. - Google Patents

Alpha-adrenergische rezeptorantagonisten.

Info

Publication number
ATE113949T1
ATE113949T1 AT89305338T AT89305338T ATE113949T1 AT E113949 T1 ATE113949 T1 AT E113949T1 AT 89305338 T AT89305338 T AT 89305338T AT 89305338 T AT89305338 T AT 89305338T AT E113949 T1 ATE113949 T1 AT E113949T1
Authority
AT
Austria
Prior art keywords
alpha
receptor antagonists
antagonists
adrenegic
adrenegic receptor
Prior art date
Application number
AT89305338T
Other languages
English (en)
Inventor
John Joseph Lafferty
Robert Michael Demarinis
Dinubhai Himatlal Shah
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE113949T1 publication Critical patent/ATE113949T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
AT89305338T 1988-06-01 1989-05-26 Alpha-adrenergische rezeptorantagonisten. ATE113949T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20100488A 1988-06-01 1988-06-01

Publications (1)

Publication Number Publication Date
ATE113949T1 true ATE113949T1 (de) 1994-11-15

Family

ID=22744083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89305338T ATE113949T1 (de) 1988-06-01 1989-05-26 Alpha-adrenergische rezeptorantagonisten.

Country Status (13)

Country Link
EP (1) EP0344979B1 (de)
JP (1) JPH03504607A (de)
KR (1) KR900701797A (de)
CN (1) CN1039810A (de)
AT (1) ATE113949T1 (de)
AU (1) AU629224B2 (de)
CA (1) CA1320953C (de)
DE (1) DE68919280T2 (de)
NZ (1) NZ229300A (de)
PT (1) PT90719B (de)
WO (1) WO1989012054A1 (de)
ZA (1) ZA894098B (de)
ZW (1) ZW6789A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ248852A (en) * 1992-10-28 1997-06-24 Squibb & Sons Inc Alpha-phosphono and phosphinosulphonates and medicaments thereof
US5712396A (en) * 1992-10-28 1998-01-27 Magnin; David R. α-phosphonosulfonate squalene synthetase inhibitors
FR2708612B1 (fr) * 1993-08-05 1996-03-01 Roussel Uclaf Nouveaux dérivés bicycliques de l'imidazole, leur procédé de préparation, les nouveaux intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant.
US5447922A (en) * 1994-08-24 1995-09-05 Bristol-Myers Squibb Company α-phosphonosulfinic squalene synthetase inhibitors
EP1939180A1 (de) * 2006-12-20 2008-07-02 sanofi-aventis Heteroarylacrylamide und ihre Verwendung als Arzneimittel für die Stimulation der Expression der endothelialen NO-Synthase
JP6198715B2 (ja) * 2012-03-06 2017-09-20 武田薬品工業株式会社 三環性化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856910A (en) * 1950-01-10 1974-12-24 Roussel Uclaf Novel thienobenzazepines as anti-depressants
US3649644A (en) * 1969-08-08 1972-03-14 Warner Lambert Co 1 2 3 4 4a 5 6 6a-octahydrobenzofuro (3 2-c)indoles
BE795451A (fr) * 1972-02-23 1973-08-16 Pfizer Agents hypoglycemiants aza indoliques tricycliques
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
JPS57144286A (en) * 1981-03-02 1982-09-06 Takeda Chem Ind Ltd Azepinoindole derivative and its preparation
US4833244A (en) * 1985-04-22 1989-05-23 Hoechst-Rouseel Pharmaceuticals Inc. Ethanobenzazepines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4769368A (en) * 1986-02-10 1988-09-06 Smithkline Beckman Corporation 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines
DE3630539A1 (de) * 1986-09-08 1988-03-10 Madaus & Co Dr Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten

Also Published As

Publication number Publication date
EP0344979B1 (de) 1994-11-09
NZ229300A (en) 1991-04-26
EP0344979A2 (de) 1989-12-06
DE68919280T2 (de) 1995-03-23
WO1989012054A1 (en) 1989-12-14
CA1320953C (en) 1993-08-03
AU3857289A (en) 1990-01-05
PT90719A (pt) 1989-12-29
AU629224B2 (en) 1992-10-01
EP0344979A3 (de) 1991-05-15
JPH03504607A (ja) 1991-10-09
KR900701797A (ko) 1990-12-04
CN1039810A (zh) 1990-02-21
PT90719B (pt) 1994-11-30
ZA894098B (en) 1990-06-27
ZW6789A1 (en) 1989-08-30
DE68919280D1 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
DE69034103D1 (de) Imidazoalkensäure
ES2131830T3 (es) Benzamidinas sustituidas, su preparacion y uso como medicamentos.
FI905481A0 (fi) Substituerade n-(imidazolyl) -alkylalaninderivat.
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
FI881609A0 (fi) Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES2067541T3 (es) Mejoras en antagonistas de la serotonina y relacionadas con ellos.
DE68919280D1 (de) Alpha-adrenergische Rezeptorantagonisten.
FI891473A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
ATE114310T1 (de) Alpha-adrenergische rezeptorantagonisten.
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ATE109483T1 (de) Alpha-adrenergische rezeptorantagonisten.
EP0344980A3 (de) Alpha-adrenergische Rezeptorantagonisten
FI873145A0 (fi) Nya tetracykliska indolderivat.
DE69505351D1 (de) Zyklische neurokinin a - antagonisten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties